Boiron Overview

  • Founded
  • 1932
  • Status
  • Public
  • Employees
  • 3,502
  • Stock Symbol
  • BOI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $38.65
  • (As of Thursday Closing)

Boiron General Information


Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Stock Exchange
Primary Office
  • 2, avenue de l'Ouest Lyonnais
  • 69510 Messimy
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boiron Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$38.65 $38.43 $28.76 - $47.22 $677M 17.5M 11.4K $2.60

Boiron Financials Summary

In Thousands,
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 526,075 526,075 779,014 1,410,887
Revenue 623,668 623,668 713,010 696,440
EBITDA 114,453 114,453 162,160 174,518
Net Income 45,483 45,483 67,805 88,240
Total Assets 856,128 856,128 877,462 960,245
Total Debt 14,580 14,580 6,854 19,165
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Boiron Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boiron‘s full profile, request access.

Request a free trial

Boiron Executive Team (4)

Name Title Board Seat Contact Info
Christian Boiron Co-Chief Executive Officer & Director
Thierry Boiron President
Véronique Bouscayrol Chief Financial Officer
Ron Gentry Vice President of Marketing
To view Boiron’s complete executive team members history, request access »

Boiron Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boiron Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boiron‘s full profile, request access.

Request a free trial

Boiron Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 07-Apr-2017 000000000000000000 00.000 Laboratory Services (Healthcare) 0000000 000000
Laboratoires Dolisos 01-Jan-2005 Merger/Acquisition Distributors (Healthcare)
To view Boiron’s complete acquisitions history, request access »